Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 28, 2026; 32(44): 117819
Published online Nov 28, 2026. doi: 10.3748/wjg.117819
Published online Nov 28, 2026. doi: 10.3748/wjg.117819
Figure 8 Effect of emodin on gut microbiota in mice with α-naphthylisothiocyanate-induced cholestasis liver injury.
A: Alpha diversity (Chao and Shannon indices) of bacteria in control, α-naphthylisothiocyanate-treated and emodin-treated mice; B: Community distribution at the phylum level; C: Community distribution at the genus level; D: Principal co-ordinates analysis of different groups at the genus level; E-H: Proportion of differential microbiota. Data were analyzed via the Wilcoxon rank-sum test. aP < 0.01 vs control group, bP < 0.001 vs control group, cP < 0.05 vs α-naphthylisothiocyanate group, and dP < 0.01 vs α-naphthylisothiocyanate group. Cont: Control; Emo: Emodin; ANIT: Α-naphthylisothiocyanate; PCoA: Principal co-ordinates analysis.
- Citation: Wang CX, Wang LM, Fu ZF, Zhao X, Han LF, Lou YF. Emodin ameliorates cholestatic liver injury by regulating bile acid metabolism and gut microbiota in mice. World J Gastroenterol 2026; 32(44): 117819
- URL: https://www.wjgnet.com/1007-9327/full/v32/i44/117819.htm
- DOI: https://dx.doi.org/10.3748/wjg.117819